Literature DB >> 7686464

Suppression of preterm labour. Current concepts.

P Johnson1.   

Abstract

Preterm delivery occurs in 5 to 9% of pregnancies and the complications of prematurity account for more than 60% of perinatal mortality. In spite of tocolytic agents being available for over 20 years, and in widespread use, there has been no decrease in the number of preterm births. Many therapeutic agents have been investigated for efficacy and safety in tocolysis, including ethanol, beta 2-adrenoceptor agonists, prostaglandin synthetase inhibitors and calcium channel blockers. While the ability to delay delivery for up to 7 days has been shown, there is little convincing evidence that any further prolongation of pregnancy can be obtained. However, the value in delaying delivery until corticosteroids can be administered has been demonstrated. Problems in diagnosing preterm labour account for much of the difficulty in interpreting the literature, and the conflicting results of clinical trials.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686464     DOI: 10.2165/00003495-199345050-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  41 in total

1.  Activation of the renin-angiotensin system during ritodrine treatment in preterm labor.

Authors:  M Hanssens; M J Keirse; E M Symonds
Journal:  Am J Obstet Gynecol       Date:  1990-04       Impact factor: 8.661

Review 2.  Preterm birth: a puzzle worth solving.

Authors:  J C Morrison
Journal:  Obstet Gynecol       Date:  1990-07       Impact factor: 7.661

3.  A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.

Authors:  G C Liggins; R N Howie
Journal:  Pediatrics       Date:  1972-10       Impact factor: 7.124

4.  Bolus tocolysis: treatment of preterm labor with pulsatile administration of a beta-adrenergic agonist.

Authors:  L Spätling; F Fallenstein; H Schneider; J Dancis
Journal:  Am J Obstet Gynecol       Date:  1989-03       Impact factor: 8.661

5.  Preterm labor: its diagnosis and management.

Authors:  B Gonik; R K Creasy
Journal:  Am J Obstet Gynecol       Date:  1986-01       Impact factor: 8.661

6.  The national impact of ritodrine hydrochloride for inhibition of preterm labor.

Authors:  K J Leveno; B B Little; F G Cunningham
Journal:  Obstet Gynecol       Date:  1990-07       Impact factor: 7.661

7.  Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. TRH Study Group.

Authors:  R A Ballard; P L Ballard; R K Creasy; J Padbury; D H Polk; M Bracken; F R Moya; I Gross
Journal:  Lancet       Date:  1992-02-29       Impact factor: 79.321

8.  Acute cutaneous vasculitis associated with prolonged intravenous ritodrine hydrochloride therapy.

Authors:  S Bosnyak; J M Baron; J Schreiber
Journal:  Am J Obstet Gynecol       Date:  1991-08       Impact factor: 8.661

9.  Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labor.

Authors:  S J Carlan; W F O'Brien; T D O'Leary; D Mastrogiannis
Journal:  Obstet Gynecol       Date:  1992-02       Impact factor: 7.661

10.  Ritodrine-induced pulmonary edema unmasking underlying peripartum cardiomyopathy.

Authors:  I Blickstein; Y Zalel; Z Katz; M Lancet
Journal:  Am J Obstet Gynecol       Date:  1988-08       Impact factor: 8.661

View more
  1 in total

Review 1.  Differences in NSAID tolerability profiles. Fact or fiction?

Authors:  K J Skeith; M Wright; P Davis
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.